NCLT Delhi held that resolution plan of corporate debtor Dev Versha Publication Private Limited submitted by resolution ...
The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.
FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback